The Rising Risks of Stem Cell Treatments and Regulatory Catch-Up

This chapter examines the rise of stem cell clinics and the regulatory hurdles they face from the FDA. It highlights the shift from low-risk treatments to more invasive procedures, underscored by a patient's experience of feeling exploited, emphasizing the need for stricter oversight.